Welsh MJ[au] - Search Results

Year	Number of Results
1963	1
1965	1
1975	1
1976	1
1977	2
1978	4
1979	1
1980	7
1981	3
1982	4
1983	11
1984	4
1985	6
1986	14
1987	6
1988	8
1989	9
1990	20
1991	17
1992	21
1993	22
1994	19
1995	25
1996	19
1997	16
1998	21
1999	23
2000	18
2001	19
2002	11
2003	15
2004	18
2005	12
2006	7
2007	9
2008	12
2009	11
2010	9
2011	9
2012	13
2013	8
2014	14
2015	8
2016	12
2017	5
2018	6
2019	4
2020	6
2021	6
2022	4

1

Origins of cystic fibrosis lung disease.

Stoltz DA, Meyerholz DK, Welsh MJ. Stoltz DA, et al. Among authors: welsh mj. N Engl J Med. 2015 Jan 22;372(4):351-62. doi: 10.1056/NEJMra1300109. N Engl J Med. 2015. PMID: 25607428 Free PMC article. Review. No abstract available.

2

Structure and function of the CFTR chloride channel.

Sheppard DN, Welsh MJ. Sheppard DN, et al. Among authors: welsh mj. Physiol Rev. 1999 Jan;79(1 Suppl):S23-45. doi: 10.1152/physrev.1999.79.1.S23. Physiol Rev. 1999. PMID: 9922375 Free article. Review.

3

Enhancing glycolysis attenuates Parkinson's disease progression in models and clinical databases.

Cai R, Zhang Y, Simmering JE, Schultz JL, Li Y, Fernandez-Carasa I, Consiglio A, Raya A, Polgreen PM, Narayanan NS, Yuan Y, Chen Z, Su W, Han Y, Zhao C, Gao L, Ji X, Welsh MJ, Liu L. Cai R, et al. Among authors: welsh mj. J Clin Invest. 2019 Oct 1;129(10):4539-4549. doi: 10.1172/JCI129987. J Clin Invest. 2019. PMID: 31524631 Free PMC article.

4

Association of Glycolysis-Enhancing α-1 Blockers With Risk of Developing Parkinson Disease.

Simmering JE, Welsh MJ, Liu L, Narayanan NS, Pottegård A. Simmering JE, et al. Among authors: welsh mj. JAMA Neurol. 2021 Apr 1;78(4):407-413. doi: 10.1001/jamaneurol.2020.5157. JAMA Neurol. 2021. PMID: 33523098 Free PMC article.

5

Molecular mechanisms of CFTR chloride channel dysfunction in cystic fibrosis.

Welsh MJ, Smith AE. Welsh MJ, et al. Cell. 1993 Jul 2;73(7):1251-4. doi: 10.1016/0092-8674(93)90353-r. Cell. 1993. PMID: 7686820 Review. No abstract available.

6

Cystic fibrosis carriers are at increased risk for a wide range of cystic fibrosis-related conditions.

Miller AC, Comellas AP, Hornick DB, Stoltz DA, Cavanaugh JE, Gerke AK, Welsh MJ, Zabner J, Polgreen PM. Miller AC, et al. Among authors: welsh mj. Proc Natl Acad Sci U S A. 2020 Jan 21;117(3):1621-1627. doi: 10.1073/pnas.1914912117. Epub 2019 Dec 27. Proc Natl Acad Sci U S A. 2020. PMID: 31882447 Free PMC article.

7

Inflammatory cytokines TNF-α and IL-17 enhance the efficacy of cystic fibrosis transmembrane conductance regulator modulators.

Rehman T, Karp PH, Tan P, Goodell BJ, Pezzulo AA, Thurman AL, Thornell IM, Durfey SL, Duffey ME, Stoltz DA, McKone EF, Singh PK, Welsh MJ. Rehman T, et al. Among authors: welsh mj. J Clin Invest. 2021 Aug 16;131(16):e150398. doi: 10.1172/JCI150398. J Clin Invest. 2021. PMID: 34166230 Free PMC article.

8

Cystic fibrosis.

Welsh MJ, Fick RB. Welsh MJ, et al. J Clin Invest. 1987 Dec;80(6):1523-6. doi: 10.1172/JCI113237. J Clin Invest. 1987. PMID: 3316277 Free PMC article. Review. No abstract available.

9

Correction.

Welsh MJ, Anderson MP. Welsh MJ, et al. Science. 1992 Dec 11;258(5089):1719. doi: 10.1126/science.258.5089.1719. Science. 1992. PMID: 17831643

10

Shocking degeneration.

Benndorf R, Welsh MJ. Benndorf R, et al. Among authors: welsh mj. Nat Genet. 2004 Jun;36(6):547-8. doi: 10.1038/ng0604-547. Nat Genet. 2004. PMID: 15167925 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results